IT vs RNAC · P/E 16, rev $6.27B vs P/E 2.1, rev $38.9M
Gartner Inc (IT) versus Cartesian Therapeutics Inc. (RNAC) — a side-by-side from cached financials, not a winner call.
Gartner Inc (IT) is a information technology services company listed on US.
Cartesian Therapeutics Inc. (RNAC) is a biotechnology company listed on US.
Latest reported IT revenue for 2024-12-31 was $6.27B. Net income was $1.25B. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. IT currently screens at market cap $11.03B and trailing P/E 16.3.
Latest reported RNAC revenue for 2024-12-31 was $38.9M. Net income was -$77.4M. Revenue was up 49.6% from 2023-12-31 to 2024-12-31. RNAC currently screens at market cap $290.9M and trailing P/E 2.1.
IT currently screens at market cap $11.03B and trailing P/E 16.3. RNAC currently screens at market cap $290.9M and trailing P/E 2.1.
Not investment advice. Open the IT and RNAC stock pages for the full models.
Not investment advice.